1.The effect of local application of neutralizing antibody to interleukin-1B on the development of vein graft intimal hyperplasia.
Ricardo Jose T Quintos II ; Darwin A Dasig ; Xenia T Tigno
Philippine Journal of Surgical Specialties 2018;73(1):8-14
OBJECTIVE: Intimal hyperplasia (IH) remains one of the major obstacles to long term vein graft patency. IL-1B has been demonstrated to be one of the first inflammatory cytokines expressed in the rat vein graft model of IH and may be an important initiator of the sequence of events leading to the development of IH. This study was designed to establish the role of IL-1B by demonstrating the outcome of inhibiting its effects by the use of neutralizing antibodies on the development of IH in this model.
METHODS: Rat epigastric vein to femoral artery interposition grafts were treated with neutralizing antibody to IL-1B suspended in pluronic gel and harvested at the end of one week and two weeks. The amount of intimal hyperplasia was measured at the anastomotic and midgraft regions.
RESULTS: The amount of IH was less at the anastomotic and midgraft regions of the treated grafts at the end of one week (p<0.05), but did not differ significantly with the untreated group at the end of two weeks.
CONCLUSION: Neutralizing antibody to IL-1B delivered locally retarded but did not prevent the occurrence of IH in vein grafts. The initiation of the cascade of events in the development of IH is affected in a major way , but not singularly by IL-1B
Animal ; Male ; Rats ; Hyperplasia ; Antibodies, Neutralizing ; Cytokines ; Poloxamer ; Femoral Artery ; Veins ; Tunica Intima ; Interleukin-1beta ; Transplants
2.A comparative study on depression and anxiety of mice (Mus musculus) on a prebiotic-supplemented diet versus a standard diet during Unpredictable Chronic Mild Stress (UCMS).
Rafael Lorenzo G. VALENZUELA ; Raphael Ian B. VELASCO ; Denzel C. UMEREZ ; Christian Roie D.L. URGENA ; Janelle Audrey C. UY ; Maria Antoinette M. VALDEZ ; Lucille Marie VILLANUEVA-UY ; Nico Angelo R. VINASOY ; Drenzell Ivann A. YU ; Darwin A. DASIG ; Leticia T. IBANEZ
Acta Medica Philippina 2022;56(7):64-72
Background. Anxiety and depression are becoming increasingly prevalent today and are often aggravated by day-to-day stresses. Because current management strategies are usually accompanied by unpleasant side effects, there is a need to look into alternative treatment regimens - such as prebiotics - that may provide equally effective anxiolytic and antidepressant effects.
Objective. Therefore, the study aims to determine the effect of a combined fructooligosaccharide (FOS) and galactooligosaccharide (GOS) supplemented diet on anxiety and depression levels in mice subjected to Unpredictable Chronic Mild Stress (UCMS).
Methods. Forty male BALB/C mice were subjected to UCMS under a pretest-posttest control group design where the treatment group received prebiotic supplementation throughout the study. Repeated measures ANOVA was run to evaluate between, within, and time interactions of the measured anxiety parameters using the light-dark box test, and depression parameter using the fur coat state assessment.
Results. Results show that (1) the FOS + GOS treatment did not give the treatment group an advantage over the control group during UCMS, (2) both groups grew more anxious and depressed over time, and (3) the treatment group grew more anxious with time in relation to control in terms of the total time spent in the light side.
Conclusion. These imply that the UCMS protocol was successful in inducing stress in mice, but the FOS + GOS regimen failed to provide anxiolytic and antidepressant effects on male BALB/C mice exposed to UCMS.
Prebiotics ; Anxiety ; Depression ;